Care of the patient preparing for organ donation after brain death is essentially the support of organ systems which have lost central autonomic and endocrine regulation. The intensivist must step in to the role of the pituitary and hypothalamus, making gross adjustments to parameters which were previously handled by this apparatus. This support consists of pituitary hormone replacement and support of the functions which were formerly performed by the autonomic nervous system. Aggressive support in general (including CPR) is justified on the grounds of it being the fulfilment of the patient's wishes, who presumably would have supported any measures which facilitate their incredibly generous act.
Questions regarding this have appeared several times in the fellowship exam. Examples include the following:
As far as useful reading material goes, one cannot go past the ANZIC statement on Brain Death and Organ Donation. At the time of writing, the recent edition is Version 3.2 (2013). The past paper questions pre-date this version, but as far as I can tell the model answers remain relevant in their key message. The specific section of interest is 4.3 ("Medical treatment of potential donors") on page 43.
In order to succeed in questions such as Question 24 from the second paper of 2005, the candidates must learn the following easily spoutable keywords, which have been emphasised in bold:
Summarized from the ANZIC statement on Brain Death and Organ Donation, Version 3.2
Dujardin, Karl S., et al. "Myocardial dysfunction associated with brain death: clinical, echocardiographic, and pathologic features." The Journal of heart and lung transplantation 20.3 (2001): 350-357.
Totsuka, Eishi, et al. "Influence of high donor serum sodium levels on early postoperative graft function in human liver transplantation: effect of correction of donor hypernatremia." Liver Transplantation and Surgery 5.5 (1999): 421-428.
Novitzky, D., D. K. C. Cooper, and B. Reichart. "Hemodynamic and metabolic responses to hormonal therapy in brain-dead potential organ donors." Transplantation 43.6 (1987): 852-854.
Phongsamran, Paula. "Critical care pharmacy in donor management." Progress in Transplantation 14.2 (2004): 105-113.
RANDELL, TARJA T., and KRISTER AV HöCKERSTEDT. "TRIIODOTHYRONINE TREATMENT IN BRAIN-DEAD MULTIORGAN DONORS-A CONTROLLED STUDY." Transplantation 54.4 (1992): 736-737.
Goarin, Jean-Pierre, et al. "The effects of triiodothyronine on hemodynamic status and cardiac function in potential heart donors." Anesthesia & Analgesia 83.1 (1996): 41-47.
Follette, David M., Steven M. Rudich, and Wayne D. Babcock. "Improved oxygenation and increased lung donor recovery with high-dose steroid administration after brain death." The Journal of heart and lung transplantation: the official publication of the International Society for Heart Transplantation 17.4 (1998): 423-429.
Lisman, T., et al. "Activation of hemostasis in brain dead organ donors: an observational study." Journal of Thrombosis and Haemostasis 9.10 (2011): 1959-1965.
Lim, H. B., and M. Smith. "Systemic complications after head injury: a clinical review." Anaesthesia 62.5 (2007): 474-482.
Dalle Ave, Anne L., Dale Gardiner, and David M. Shaw. "Cardio‐pulmonary resuscitation of brain‐dead organ donors: a literature review and suggestions for practice." Transplant International (2015).
Singer, Pierre, Haim Shapiro, and Jonathan Cohen. "Brain death and organ damage: the modulating effects of nutrition." Transplantation 80.10 (2005): 1363-1368.